NASDAQ:MMSI Merit Medical Systems (MMSI) Stock Price, News & Analysis $60.89 -1.16 (-1.87%) Closing price 04:00 PM EasternExtended Trading$60.90 +0.01 (+0.01%) As of 05:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Merit Medical Systems Stock (NASDAQ:MMSI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Merit Medical Systems alerts:Sign Up Key Stats Today's Range$60.38▼$61.8550-Day Range$60.31▼$70.9352-Week Range$59.74▼$96.74Volume787,447 shsAverage Volume786,376 shsMarket Capitalization$3.63 billionP/E Ratio26.36Dividend YieldN/APrice Target$92.80Consensus RatingModerate Buy Company Overview Merit Medical Systems, Inc. is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy. Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach. Headquartered in South Jordan, Utah, the company operates manufacturing and distribution facilities in North America, Europe and Asia. Merit’s products are sold in over 90 countries worldwide, with regional sales offices in Europe, Latin America and the Asia‐Pacific region to support local clinical training and customer service. Under the leadership of founder and CEO Fred Lampropoulos, Merit Medical Systems has maintained a focus on innovation, quality and customer education. The company invests in research and development to evolve its product pipeline and partners with healthcare professionals to improve procedural outcomes. Merit’s commitment to minimally invasive care and patient safety has positioned it as a key supplier to hospitals and health systems seeking advanced device solutions for complex diagnostic and therapeutic procedures.AI Generated. May Contain Errors. Read More Merit Medical Systems Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks95th Percentile Overall ScoreMMSI MarketRank™: Merit Medical Systems scored higher than 95% of companies evaluated by MarketBeat, and ranked 34th out of 869 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingMerit Medical Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on no strong buy ratings, 8 buy ratings, 2 hold ratings, and 1 sell rating.Upside PotentialMerit Medical Systems has a consensus price target of $92.80, representing about 52.1% upside from its current price of $61.03.Amount of Analyst CoverageMerit Medical Systems has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Merit Medical Systems' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth8.84% Earnings GrowthEarnings for Merit Medical Systems are expected to grow by 8.84% in the coming year, from $3.62 to $3.94 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Merit Medical Systems is 26.70, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.28.Price to Earnings Ratio vs. SectorThe P/E ratio of Merit Medical Systems is 26.70, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 21.16.Price to Earnings Growth RatioMerit Medical Systems has a PEG Ratio of 1.96. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioMerit Medical Systems has a P/B Ratio of 2.28. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Merit Medical Systems' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.86% of the float of Merit Medical Systems has been sold short.Short Interest Ratio / Days to CoverMerit Medical Systems has a short interest ratio ("days to cover") of 2.61, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Merit Medical Systems has recently decreased by 11.25%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMerit Medical Systems does not currently pay a dividend.Dividend GrowthMerit Medical Systems does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.94 News SentimentMerit Medical Systems has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.81 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Merit Medical Systems this week, compared to 5 articles on an average week.Search Interest4 people have searched for MMSI on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership2.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Merit Medical Systems insiders have sold 149.96% more of their company's stock than they have bought. Specifically, they have bought $125,240.00 in company stock and sold $313,050.00 in company stock.Percentage Held by Insiders0.70% of the stock of Merit Medical Systems is held by insiders.Percentage Held by Institutions99.66% of the stock of Merit Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Merit Medical Systems' insider trading history. Receive MMSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MMSI Stock News HeadlinesMerit Medical Systems Inc (MMSI) Shares Fall 3.1% -- What GF Score of 79 Tells InvestorsMay 27, 2026 | gurufocus.com2 Reasons to Avoid MMSI and 1 Stock to Buy InsteadMay 26, 2026 | finance.yahoo.comMusk is burning $2.5 billion a quarter on AI. One company holds the key.SpaceX's S-1 filing reveals $7.7 billion spent on AI infrastructure in a single quarter - not chips, not software, but power infrastructure. The filing shows $23.85 billion in servers and $14 billion in construction in progress, all dependent on one company's hardware. Without this supplier, Colossus doesn't run and the $1.25 billion Anthropic pays monthly stops flowing. The stock is still trading like no one has read the filing - but analyst Dylan Jovine has, and he's releasing the name at no cost.June 2 at 1:00 AM | Behind the Markets (Ad)Merit Medical Systems, Inc. (NASDAQ:MMSI) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesMay 25, 2026 | americanbankingnews.comZacks Research Analysts Lower Earnings Estimates for MMSIMay 25, 2026 | americanbankingnews.comMerit Medical Updates Governance and Elects New DirectorMay 19, 2026 | tipranks.comMerit Medical Systems Elects Scott R. Ward to Board of DirectorsMay 19, 2026 | quiverquant.comQBrian Lloyd Buys 2,000 Shares of Merit Medical Systems (NASDAQ:MMSI) StockMay 12, 2026 | insidertrades.comSee More Headlines MMSI Stock Analysis - Frequently Asked Questions How have MMSI shares performed this year? Merit Medical Systems' stock was trading at $88.14 at the beginning of the year. Since then, MMSI stock has decreased by 30.8% and is now trading at $61.0280. How were Merit Medical Systems' earnings last quarter? Merit Medical Systems, Inc. (NASDAQ:MMSI) issued its earnings results on Thursday, April, 30th. The medical instruments supplier reported $0.94 EPS for the quarter, topping analysts' consensus estimates of $0.84 by $0.10. Merit Medical Systems's revenue was up 7.4% on a year-over-year basis. Read the conference call transcript. Does Merit Medical Systems have any subsidiaries? Merit Medical Systems subsidiaries include Fibrovein Holdings Limited, Brightwater Medical Inc., Vascular Insights LLC, Cianna Medical Inc., DFINE Inc., BioSphere Medical SA, Alveolus Inc., and others. Who are Merit Medical Systems' major shareholders? Merit Medical Systems' top institutional investors include Conestoga Capital Advisors LLC (3.63%), Dimensional Fund Advisors LP (2.07%), Royal Bank of Canada (1.54%) and Maverick Capital Ltd. (1.20%). Insiders that own company stock include Fred P Lampropoulos, A Scott Anderson, Joseph Wright, F Ann Millner, Raul Jr Parra, Thomas James Gunderson, Neil Peterson, Lynne N Ward, David Floyd, Stephen C Evans and Brian G Lloyd. View institutional ownership trends. How do I buy shares of Merit Medical Systems? Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Merit Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Merit Medical Systems investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR) and AUO (AUOTY). Company Calendar Last Earnings4/30/2026Today6/02/2026Goldman Sachs 47th Annual Global Healthcare Conference 20266/08/2026Next Earnings (Estimated)7/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (10m+) 1-Year History Jun 25 Sep 25 Dec 25 Mar 26 Jun 26 MMSI's financial health is in the Red zone, according to TradeSmith. MMSI has been in this zone for over 10 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED/DENTAL - SUPP Sub-IndustryHealth Care Supplies Current SymbolNASDAQ:MMSI CIK856982 Webwww.merit.com Phone(801) 253-1600Fax801-253-1652Employees7,500Year Founded1987Price Target and Rating Average Price Target for Merit Medical Systems$92.80 High Price Target$107.00 Low Price Target$74.00 Potential Upside/Downside+52.4%Consensus RatingModerate Buy Rating Score (0-4)2.64 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)$2.31 Trailing P/E Ratio26.36 Forward P/E Ratio16.82 P/E Growth1.96Net Income$128.49 million Net Margins9.03% Pretax Margin12.09% Return on Equity13.54% Return on Assets7.94% Debt Debt-to-Equity Ratio0.45 Current Ratio5.08 Quick Ratio3.46 Sales & Book Value Annual Sales$1.54 billion Price / Sales2.35 Cash Flow$5.67 per share Price / Cash Flow10.73 Book Value$26.72 per share Price / Book2.28Miscellaneous Outstanding Shares59,655,000Free Float59,237,000Market Cap$3.63 billion OptionableOptionable Beta0.58 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:MMSI) was last updated on 6/2/2026 by MarketBeat.com Staff. From Our PartnersHow to claim a stake in SpaceX before the June 12 IPOSpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | SponsoredI paid $5,000 to hear Elon say thisOne investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...InvestorPlace | SponsoredPresident Trump just sparked a stock market MELT UPThe real reason Musk, Huang, Cook, and Fink just flew to Beijing Last week, the CEOs of Nvidia, Apple, Spac...Stansberry Research | SponsoredGiving “2022 pre-ChatGPT” vibes (but 10x bigger)When ChatGPT launched in 2022, Nvidia surged 1,800% over three years. Now, Nvidia's CEO suggests July 22nd cou...StocksToTrade | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merit Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Merit Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
